TGen/Dell/Intel collaboration optimizes genomic sequencing

Ahead of BioData World Congress we wanted to share some examples of where high-performance computing is having a real and meaningful impact on scientific research.

With ‘From Bench to Bedside’ as its motto, TGen launched in June 2002 and today anchors a rising biosciences hub in Phoenix, Arizona. The non-profit institute is at the forefront of efforts to bring next-generation genomic sequencing (NGS) out of the research environment and use it to transform the way we diagnose, treat and prevent illness.

Using Intel and Dell technology, TGen has been able to reduce the time it takes to process a genome from weeks to hours while meeting the demands of delivering affordable, energy-efficient performance to match ever-increasing volumes of clinical genomics data.

  • Watch this video and download the TGen Case Study to learn more about how technology can help your organisation solve complex data problems and deliver precision medicine at the point of care.
  • Find out more about how IntelĀ® technologies power today’s data set management and analytic tools, helping health and life sciences optimize diagnostics, treatment and care delivery.
  • Follow @intelhealth on Twitter


Intel is a Silver Sponsor for BioData World Congress. Join the event on the 21-22 October 2015 at Wellcome Genome Camus, Cambridge to meet them!

Leave a Reply

Your email address will not be published. Required fields are marked *